semaglutide zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs – Tirzepatide vs. Semaglutide for Weight

Our clinical team is here to help you through every stage of your treatment plan

In 2024, a Cambridge University graduate named Paloma Shemirani was diagnosed with non-Hodgkins lymphoma, a type of cancer that her doctors told her has an 80 percent survival rate when treated with chemotherapy

2025;9:e0599

Board-certified obesity and anti-aging specialists On-site phlebotomy, DEXA, and ultrasound to track visceral-fat changes Compounded peptides from FDA-registered 503B pharmacies Integrated programs that layer GLP-1, body-contouring, and nutrition coaching for synergistic outcomes 10

Un reciente metaanlisis65, que incluy 21 estudios clnicos aleatorizados y 3.395 sujetos asignados a agonistas del GLP-1 (la liraglutida y la exenatida) y 3.016 individuos asignados a control (placebo, antidiabticos orales, insulina) mostr un efecto beneficioso de los agonistas del receptor GLP-1 en la prdida de peso en pacientes con sobrepeso y obesidad, con o sin DM2

Retatrutide is still investigational and not yet FDA-approved, but its expected to become available by 2026 or 2027